P2 PMDIs: pressurised metered dose inhalers

0.0(0)
studied byStudied by 0 people
full-widthCall with Kai
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/18

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

19 Terms

1
New cards

What is PMDI

compact pressurised aerosol dispenser

most common

25ug-5mg

<p>compact pressurised aerosol dispenser</p><p>most common </p><p>25ug-5mg </p>
2
New cards

advantage of pmdi

Large dose range

several hundred accurately metered measured doses

•Many doses

•Compact

•Consistent delivery

•Relatively cheap

•Sealed canister protects drug

•Lower capital costs for market entry

3
New cards

disadvantage pmdi

•Patient co-ordination and force required to actuate

•“Cold Freon Effect”

•Tail off at the end of a can

•Force of aerosol spray

•Varying deposition pattern in airways

•Minimum IP protection for pharmaceutical industry

4
New cards

Propellant

Gas compressed to 300-500 kPa

Converts to liquid

Liquid rapidly boils to form a gas

Leaving behind an aerosol of drug particles

Made from hydrofluroalkanes used to be CFC as they destroy ozone layer

5
New cards

Metering valve

At rest

Start of actuation

Dose release

6
New cards

How is the spray formed

Ligaments shear

Particles released are slightly too large but they evaporate decreasing their size

7
New cards

Actuator

it is the component in any machine that enables movement.

8
New cards

Describe the types of drug particles used in pMDIs

  1. If drug is insoluble like solid particles suspended in solution= suspension

  1. The more soluble the drug the more drug in each droplet = larger particle size

  2. Add another non-volatile (non-evaporating) liquid e.g. glycerine when the particle is too small

9
New cards

Advantages/ Disadvantages of suspension formulation

Deliver high powder doses

Disadvantages:

Requires milling or micro ionised

Requires drug to be insoluble other leads to changes in particle size going to other parts of the body

Requires drug to be freely dispersed

Homogeneity + physical stability as particles disperse = shake vigorously

10
New cards

List and define 5 types of physical instability

Rapid Flocculation - Loose Agglomerates  (Interparticulate Forces)

Bulk Separation - Creaming or Sedimentation (Density, Particle Size). Creaming = rise to the top. Sedimentation= sink to the bottom. Drug at the top is not delivered

Irreversible Aggregation - Ostwald Ripening, Crystal Growth and Caking (Solubility)

Crystal Structure Instability - Polymorphic interconversion (different crystal structure)

Adhesion to the canister – inside surface often coated, e.g. PTFE

<p><span>•<strong>Rapid Flocculation </strong>- Loose Agglomerates&nbsp; (Interparticulate Forces)</span></p><p><span>•<strong>Bulk Separation </strong>- Creaming or Sedimentation (Density, Particle Size). Creaming = rise to the top. Sedimentation= sink to the bottom. Drug at the top is not delivered </span></p><p><span>•<strong>Irreversible Aggregation </strong>- Ostwald Ripening, Crystal Growth and Caking (Solubility)</span></p><p><span>•<strong>Crystal Structure Instability </strong>- Polymorphic interconversion (different crystal structure)</span></p><p><span>•<strong>Adhesion to the canister</strong> – inside surface often coated, e.g. PTFE</span></p><p></p>
11
New cards

Flocculation

Clumping/ aggregation of particles that don’t break when shaken

So important to shake to remove clumps and create uniform suspension

<p>Clumping/ aggregation of particles that don’t break when shaken</p><p>So important to shake to remove clumps and create uniform suspension</p>
12
New cards

What is the purpose of excipients

Enhance physical stability of a drug

Allows dispersing + redispersion + homogenous distribution

Prevents segregation

Examples: Oleic acid, Magnesium Stearate, PEG

13
New cards

Solution based formulation

Only used if solubility and stability is adequate as it can lead to chemical reactions may lead to crystallisation during shelf life

MORE DRUG DISSOLVED = HIGHER DOSE OUT

Requires co-solvent e.g. ethanol

<p>Only used if solubility and stability is adequate as it can lead to chemical reactions may lead to crystallisation during shelf life </p><p>MORE DRUG DISSOLVED = HIGHER DOSE OUT</p><p>Requires co-solvent e.g. ethanol</p>
14
New cards

Solution disadvantages

•Co-solvent can cause corrosion of aluminium canister

•Drugs can be relatively unstable.

•Co-solvent lowers the internal propellant pressure, thus, atomisation is less effective.

•Modification of drug chemical structure

15
New cards

How to test pMDI formulation

•Sedimentation rates

•Particle size changes

•Microscopy

•Dose uniformity measurements

•Ultimate test – uniformity in the aerosol dose

•Need a consistent dose

•Particle size distribution must be consistent

16
New cards

How do we measure particle size in aerosol dose

Use an impactor

Spray inhaler

Into throat mimetic

particles into collecting pan with different hole sizes

smaller and smaller particles collected

Divides aerosol cloud into 8 different compartments

Wash the pans, dissolve into solvent and can measure concentration and dose distributed into lungs

ensures same particle size distribution over time/ shelf-life and over each compartment = same performance

<p>Use an impactor </p><p>Spray inhaler</p><p>Into throat mimetic </p><p>particles into collecting pan with different hole sizes </p><p>smaller and smaller particles collected </p><p>Divides aerosol cloud into 8 different compartments </p><p>Wash the pans, dissolve into solvent and can measure concentration and dose distributed into lungs </p><p>ensures same particle size distribution over time/ shelf-life and over each compartment = same performance </p><p></p>
17
New cards

PMDI technique

•Shake before use.

•Breath out as far as comfortably possible away from the inhaler

•Place inhaler in mouth, inhale slowly while simultaneously pressing the canister.

•Continue to inhale slowly until lungs full

•Hold breath for around 10 seconds

•Only 20-25% of patients perform these

     essential instructions.

•More can follow DPI instructions.

18
New cards

List some patient problems with PMDIs

Incorrect use e.g. not removing cap, don’t shake, forget to inhale, don’t hold breath, don’t exhale slowly

Actuation at start inhalation leads to poorly controlled asthma

Comorbidities e.g. arthritis find it difficult to press

19
New cards

Examples of training devices

In-check dial

Vitalograph AIM

Dose counters